Aktienanalyse zu Celsius Holdings, Inc. (CELH)CELHCelsius Holdings, Inc.

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).

Celsius Holdings Inc is not a strong buy right now. The current price is $28.19, which is significantly below the analyst price targets of $42 and $45. However, the stock has experienced a year-to-date decline of 40.96%, indicating potential value but also significant risk. The RSI is at 56.165, suggesting the stock is neither overbought nor oversold. The main risk is the recent downgrade by Deutsche Bank, which cites fundamental challenges and a lack of confidence in a quick recovery, with a price target of $35.

1 analysts cover CELH: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 62.85.